title: Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer.
abstract: Merkel cell polyomavirus (MCPyV or MCV) is the first polyomavirus to be clearly implicated as a causal agent underlying a human cancer, Merkel cell carcinoma (MCC). Infection with MCPyV is common in the general population, and a majority of adults shed MCPyV from the surface of their skin. In this study, we quantitated MCPyV DNA in skin swab specimens from healthy volunteers sampled at different anatomical sites over time periods ranging from 3 months to 4 years. The volunteers were also tested using a serological assay that detects antibodies specific for the MCPyV virion. There was a positive correlation between MCPyV virion-specific antibody titers and viral load at all anatomical sites tested (dorsal portion of the hands, forehead, and buttocks) (Spearman's r 0.644, P < 0.0001). The study results are consistent with previous findings suggesting that the skin is primary site of chronic MCPyV infection in healthy adults and suggest that the magnitude of an individual's seroresponsiveness against the MCPyV virion generally reflects the overall MCPyV DNA load across wide areas of the skin. In light of previous reports indicating a correlation between MCC and strong MCPyV-specific seroresponsiveness, this model suggests that poorly controlled chronic MCPyV infection might be a risk factor in the development of MCC.
authors: Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
authors: Diana V
authors: DV
authors: Pastrana
authors: Ulrike
authors: U
authors: Wieland
authors: Steffi
authors: S
authors: Silling
authors: Christopher B
authors: CB
authors: Buck
authors: Herbert
authors: H
authors: Pfister
references: J Natl Cancer Inst. 2009 Nov 4;101(21):1510-22
references: 19776382
references: Arch Pathol Lab Med. 2005 Jan;129(1):69-73
references: 15628910
references: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30
references: 17392433
references: Science. 2008 Feb 22;319(5866):1096-100
references: 18202256
references: J Infect Dis. 1983 Apr;147(4):676-84
references: 6302172
references: Int J Cancer. 2009 Sep 15;125(6):1250-6
references: 19499548
references: Emerg Infect Dis. 2009 Sep;15(9):1496-8
references: 19788824
references: Int J Cancer. 2007 Sep 1;121(5):1098-102
references: 17471560
references: Adv Exp Med Biol. 2006;577:201-12
references: 16626038
references: Cell Host Microbe. 2010 Jun 25;7(6):509-15
references: 20542254
references: J Virol. 2009 Jan;83(2):811-6
references: 18987132
references: J Occup Environ Hyg. 2008 Jun;5(6):347-52
references: 18357546
references: J Infect Dis. 1990 Jun;161(6):1128-33
references: 2161040
references: Emerg Infect Dis. 2007 Nov;13(11):1769-72
references: 18217568
references: J Virol. 2004 Jan;78(2):751-7
references: 14694107
references: J Clin Microbiol. 2006 Jan;44(1):47-50
references: 16390946
references: Int J Cancer. 2010 Jun 15;126(12):2991-6
references: 19588496
references: Emerg Infect Dis. 2010 Apr;16(4):685-7
references: 20350388
references: Am J Transplant. 2005 Sep;5(9):2213-21
references: 16095500
references: Clin Vaccine Immunol. 2008 Oct;15(10):1564-71
references: 18753339
references: Int J Cancer. 1995 Jan 17;60(2):156-9
references: 7829207
references: PLoS Pathog. 2009 Mar;5(3):e1000363
references: 19325891
references: PLoS Pathog. 2009 Sep;5(9):e1000578
references: 19750217
references: J Med Virol. 1981;8(2):143-50
references: 6271922
references: J Clin Microbiol. 2007 Jan;45(1):193-8
references: 17093017
references: J Clin Microbiol. 1980 Feb;11(2):178-83
references: 6244330
references: J Natl Cancer Inst. 2009 Jul 1;101(13):938-45
references: 19535775
references: Clin Infect Dis. 2010 Aug 1;51(3):274-9
references: 20575664